Jazz Pharmaceuticals (JAZZ) Interest & Investment Income (2010 - 2026)
Jazz Pharmaceuticals' quarterly Interest & Investment Income came in at -$39.9 million in Q1 2026, up 25.7% year-on-year from -$31.7 million in Q1 2025, and up 12.13% quarter-over-quarter from -$45.4 million in Q4 2025.
Jazz Pharmaceuticals has reported Interest & Investment Income for 17 years, with the latest figure at -$39.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 25.7% year-over-year to -$39.9 million; the trailing twelve-month figure through Mar 2026 stood at -$181.2 million (up 19.69% YoY), and the FY2025 full-year result was -$195.1 million, up 18.08% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$39.9 million, up from -$45.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was -$39.9 million in Q1 2026, with the low at -$80.2 million in Q3 2022.
- Average Interest & Investment Income over 5 years is -$61.8 million, with a median of -$63.2 million recorded in 2022.
- Year-over-year, Interest & Investment Income sank 158.2% in 2022 and gained 27.11% in 2024.
- Tracing JAZZ's Interest & Investment Income over 5 years: stood at -$74.1 million in 2022, then rose by 5.13% to -$70.3 million in 2023, then grew by 27.11% to -$51.3 million in 2024, then increased by 11.41% to -$45.4 million in 2025, then advanced by 12.13% to -$39.9 million in 2026.
- The last three Interest & Investment Income figures came in at -$39.9 million (Q1 2026), -$45.4 million (Q4 2025), and -$48.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | -39.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.90 Mn |
| Dec 31, 2025 | -45.41 Mn |
| Sep 30, 2025 | -48.58 Mn |
| Jun 30, 2025 | -47.36 Mn |
| Mar 31, 2025 | -53.70 Mn |
| Dec 31, 2024 | -51.26 Mn |
| Sep 30, 2024 | -58.70 Mn |
| Jun 30, 2024 | -62.02 Mn |
| Mar 31, 2024 | -66.12 Mn |
| Dec 31, 2023 | -70.32 Mn |
| Sep 30, 2023 | -71.50 Mn |
| Jun 30, 2023 | -73.47 Mn |
| Mar 31, 2023 | -74.15 Mn |
| Dec 31, 2022 | -74.13 Mn |
| Sep 30, 2022 | -80.24 Mn |
| Jun 30, 2022 | -63.19 Mn |
| Mar 31, 2022 | -70.68 Mn |
| Dec 31, 2021 | -88.60 Mn |
| Sep 30, 2021 | -93.37 Mn |
| Jun 30, 2021 | -69.42 Mn |
| Mar 31, 2021 | -27.38 Mn |
| Dec 31, 2020 | -27.57 Mn |
| Sep 30, 2020 | -27.43 Mn |
| Jun 30, 2020 | -26.21 Mn |
| Mar 31, 2020 | -18.50 Mn |
| Dec 31, 2019 | -18.24 Mn |
| Sep 30, 2019 | -17.86 Mn |
| Jun 30, 2019 | -18.23 Mn |
| Mar 31, 2019 | -17.92 Mn |
| Dec 31, 2018 | -19.33 Mn |
| Sep 30, 2018 | -18.92 Mn |
| Jun 30, 2018 | -19.65 Mn |
| Mar 31, 2018 | -20.61 Mn |
| Dec 31, 2017 | -21.43 Mn |
| Sep 30, 2017 | -19.19 Mn |
| Jun 30, 2017 | -18.29 Mn |
| Mar 31, 2017 | -18.84 Mn |
| Dec 31, 2016 | -19.13 Mn |
| Sep 30, 2016 | -18.50 Mn |
| Jun 30, 2016 | -12.12 Mn |
| Mar 31, 2016 | -12.19 Mn |
| Dec 31, 2015 | -12.21 Mn |
| Sep 30, 2015 | -12.65 Mn |
| Jun 30, 2015 | -15.81 Mn |
| Mar 31, 2015 | -16.25 Mn |
| Dec 31, 2014 | -16.68 Mn |
| Sep 30, 2014 | -14.53 Mn |
| Jun 30, 2014 | -11.43 Mn |
| Mar 31, 2014 | -10.08 Mn |
| Sep 30, 2013 | -6.20 Mn |
| Jun 30, 2013 | -7.14 Mn |
| Mar 31, 2013 | -7.40 Mn |
| Dec 31, 2012 | -7.67 Mn |
| Sep 30, 2012 | -7.75 Mn |
| Jun 30, 2012 | -1.48 Mn |
| Mar 31, 2012 | 13,000.00 |
| Dec 31, 2011 | -41,000.00 |
| Sep 30, 2011 | -125,000.00 |
| Jun 30, 2011 | -657,000.00 |
| Dec 31, 2010 | -12.73 Mn |
| Sep 30, 2010 | -3,000.00 |
| Jun 30, 2010 | 4,000.00 |